MedTrace Logo

A Randomized Cross-over Trial of the Postprandial Effects of Three Different Diets in Patients With Type 2 Diabetes

NCT01522157 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2013-12-02

No results posted yet for this study

Summary

The trial will study the acute metabolic effects of three different types of diet: low-fat diet, low-carbohydrate diet and Mediterranean diet. About 20 patients with diabetes mellitus type 2 will be recruited and each of them will be given each type of diet on three different days. Menus with the same energy content but with different content of fat, carbohydrate and protein are designed. Breakfast and lunch are served for the patients each day of testing. Laboratory samplings are performed six times during the day. The order of the dietary intervention is randomized for each patient.

The investigators suppose to find different reaction in plasma glucose and lipids depending on the type of diet.

Conditions

Interventions

DIETARY_SUPPLEMENT

Low-fat Diet

Low-fat Diet is provided for a breakfast and a lunch.

DIETARY_SUPPLEMENT

Low-carbohydrate Diet

Low-carbohydrate Diet is provided for a breakfast and a lunch.

DIETARY_SUPPLEMENT

Mediterranean Diet

Mediterranean Diet is provided for a breakfast and a lunch.

Sponsors & Collaborators

  • Vårdcentralen Lyckorna

    lead OTHER

Principal Investigators

  • Fredrik H Nystrom, Professor · Department of Endocrinology Linköping University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01522157 on ClinicalTrials.gov